Sign in

CIK 0000014272 · Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
220790350
Phone
6092524621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Massacesi Cristian −$403K EVP,Chief Med Offr,Head of Dev sold 25% of stake
  2. Haller Julia A −$241K Director sold 11% of stake
  3. Holzer Phil M −$34K SVP and Controller sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-09-14 Powell Ann EVP, Chief Human Resources Sale −25,000 $70.75 $1.8M 50,476.09
2022-09-13 Elkins David V EVP, Chief Financial Officer Sale −30,000 $71.35 $2.1M 100,460
2022-09-13 Elkins David V EVP, Chief Financial Officer Option exercise +2,063 $48.49 $100K 102,523
2022-09-13 Elkins David V EVP, Chief Financial Officer Option exercise +121,214 $48.49 $5.9M 223,737
2022-09-13 Elkins David V EVP, Chief Financial Officer Sale −103,951 $71.29 $7.4M 119,786
2022-09-13 Elkins David V EVP, Chief Financial Officer Option exercise · Option (right to buy) −2,063 0
2022-09-13 Elkins David V EVP, Chief Financial Officer Option exercise · Option (right to buy) −121,214 0
2022-07-01 Weese Michelle EVP, Corporate Affairs Option exercise +1,885 1,885
2022-07-01 Weese Michelle EVP, Corporate Affairs Shares withheld for taxes −682 $76.84 $52K 1,203
2022-07-01 Weese Michelle EVP, Corporate Affairs Option exercise · Restricted Stock Units −1,885 5,655
2022-07-01 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +9,356 26,078
2022-07-01 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −4,786 $76.84 $368K 21,292
2022-07-01 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Restricted Stock Units −9,356 9,357
2022-06-30 YALE PHYLLIS R Director Grant or award · Deferred Share Units +438.31 $77.00 $34K 15,400.31
2022-06-30 Arduini Peter J Director Grant or award · Deferred Share Units +438.31 $77.00 $34K 38,979.65
2022-06-30 Hidalgo Medina Manuel Director Grant or award · Deferred Share Units +97.4 $77.00 $8K 5,589.45
2022-06-30 Storch Gerald L Director Grant or award · Deferred Share Units +470.78 $77.00 $36K 71,990.81
2022-06-30 Rice Derica W Director Grant or award · Deferred Share Units +470.78 $77.00 $36K 11,407.8
2022-06-30 Bhatt Deepak Director Grant or award · Deferred Share Units +18.15 $77.00 $1K 1,755.15
2022-06-30 Haller Julia A Director Grant or award · Deferred Share Units +438.31 $77.00 $34K 15,654.67

Page 55 of 56 · 1,112 trades